SUSITABART
UNII V2AZ4VD49V

Substance Identification & Data

This profile provides standardized clinical and technical data for Susitabart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) V2AZ4VD49V.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3095642-29-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

V2AZ4VD49V

CAS Registry Number

3095642-29-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SUSITABART

Official standardized name for this substance within the FDA UNII nomenclature system.

INN ID

14240

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

Susitabart

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Susitabart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

Susitabart

Common Names & Synonyms

Gamma1 heavy chain humanized (1-450) [VH (Homo sapiens IGHV1-18*01 (85.7%) -(IGHD) -IGHJ4*01 (93.3%), CDR-IMGT [8.8.13] (26-33.51-58.97-109)) (1-120) -Homo sapiens IGHG1*03v, G1m3>G1m17, nG1m1, CH1 K120, CH3 E12, M14, 6-G1v14-1 CH2 A1.3, A1.2, A1, 9-G1v21 CH2 Y15.1, T16, E18, 16-G1v116 C84.4 (CH1 R120>K (217) (121-218), hinge 1-15 (219-233), CH2 L1.3>A (237), L1.2>A (238), G1>A (240), M15.1>Y (255), S16>T (257), T18>E (259), N84.4>C (300) (234-343), CH3 E12 (359), M14 (361) (344-448), CHS (449-450)) (121-450)], (223-213')-disulfide with L-kappa light chain humanized (1'-213') [V-KAPPA (Homo sapiens IGKV3-11*02 (85.3%) -IGKJ4*01 (100%), CDR-IMGT [5.3.9] (27'-31'.49'-51'.88'-96')) (1'-106') -Homo sapiens IGKC*01 (100%) Km3 A45.1, V101 (C-KAPPA A45.1 (152'), V101 (190')) (107'-213')]; dimer (229-229'':232-232'')-bisdisulfide, produced in Chinese hamster ovary (CHO) cells, cell line CHO-DG44, nonglycosylated

Immunoglobulin G1 [237-alanine,238-alanine,240-alanine,255-tyrosine,257-threonine,259-glutamic acid,300-cysteine], anti-(human transmembrane protein TM4SF1) (human-Mus musculus monoclonal AN46 γ1-chain), disulfide with human-Mus musculus monoclonal AN46 κ-chain, dimer

Immunoglobulin G1-kappa, anti-[Homo sapiens TM4SF1 (transmembrane 4 L6 family member 1)], humanized monoclonal antibody

susitabart [INN]

External Clinical & Regulatory Resources

Previous UNIIV2AN5TVG47

Next UNIIV2B52UR279